FYN and Alzheimer disease: Consistently, the increased tyrosine phosphorylation of target proteins can be blocked by the addition of TK inhibitors suggesting that Fyn hyperactivity might be pharmacologically targeted to delay degenerative processes in AD [6,174,176,215,216].